サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：プレガバリンの世界市場（2022年～2028年）：剤形別、用途別、医薬品クラス別、エンドユーザー別、流通チャネル別、地域別の市場規模調査と予測
市場調査レポート
商品コード
1084125

プレガバリンの世界市場（2022年～2028年）：剤形別、用途別、医薬品クラス別、エンドユーザー別、流通チャネル別、地域別の市場規模調査と予測

Global Pregabalin Market Size study, By Dosage Forms, By Application, By Drug Class, By End-Users, By Distribution Channel, and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
プレガバリンの世界市場（2022年～2028年）：剤形別、用途別、医薬品クラス別、エンドユーザー別、流通チャネル別、地域別の市場規模調査と予測
出版日: 2022年05月31日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のプレガバリンの市場規模は、2022年～2028年の予測期間中に健全な成長率で拡大すると予想されています。市場を牽引する主な要因には、世界のてんかん有病率の上昇、リリカ（プレガバリン）の用途の増加、医療費の増加などがあります。しかし、プレガバリンに関連する副作用は、予測期間において市場の成長を阻害します。

当レポートでは、世界のプレガバリン市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界のプレガバリン市場：定義と範囲

第3章 世界のプレガバリン：市場力学

  • プレガバリン市場：影響分析（2020年～2028年）

第4章 世界のプレガバリン市場：業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要な投資機会
  • 主要な成功戦略

第5章 リスク評価：COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19以前およびCOVID-19後の市場シナリオ

第6章 世界のプレガバリン市場：用途別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • てんかん
    • 神経因性疼痛
    • 不安障害
    • その他

第7章 世界のプレガバリン市場：医薬品クラス別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • 線維筋痛症エージェント
    • 抗けいれん薬
    • その他

第8章 世界のプレガバリン市場：剤形別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • 経口カプセル
    • 経口液剤
    • 経口錠剤
    • 徐放性

第9章 世界のプレガバリン市場：エンドユーザー別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • 病院
    • 専門診療所
    • 在宅医療
    • その他

第10章 世界のプレガバリン市場：流通チャネル別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • 病院薬局
    • 小売薬局
    • オンライン薬局
    • その他

第11章 世界のプレガバリン市場：地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第12章 競合情勢

  • 主な市場戦略
  • 企業プロファイル
    • Pfizer Inc.（米国）
    • GlaxoSmithKline plc（英国）
    • Novartis AG（スイス）
    • Mylan N.V.（米国）
    • Teva Pharmaceutical Industries Ltd.（イスラエル）
    • Sanofi（フランス）
    • F. Hoffmann-La Roche Ltd.（スイス）
    • Aurobindo Pharma（インド）
    • Lupin（インド）
    • Zydus Cadila（インド）

第13章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Pregabalin Market, report scope
  • TABLE 2. Global Pregabalin Market estimates & forecasts by Region 2018-2028 (USD Million)
  • TABLE 3. Global Pregabalin Market estimates & forecasts by Application 2018-2028 (USD Million)
  • TABLE 4. Global Pregabalin Market estimates & forecasts by Drug Class 2018-2028 (USD Million)
  • TABLE 5. Global Pregabalin Market estimates & forecasts by Dosage Forms 2018-2028 (USD Million)
  • TABLE 6. Global Pregabalin Market estimates & forecasts by End-Users 2018-2028 (USD Million)
  • TABLE 7. Global Pregabalin Market estimates & forecasts by Distribution Channel 2018-2028 (USD Million)
  • TABLE 8. Global Pregabalin Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Pregabalin Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Pregabalin Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Pregabalin Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Pregabalin Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Pregabalin Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Pregabalin Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. Global Pregabalin Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. Global Pregabalin Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 17. Global Pregabalin Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 18. U.S. Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 19. U.S. Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 20. U.S. Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 21. Canada Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 22. Canada Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 23. Canada Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 24. UK Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 25. UK Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 26. UK Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 27. Germany Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 28. Germany Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 29. Germany Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 30. RoE Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 31. RoE Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 32. RoE Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 33. China Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 34. China Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 35. China Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 36. India Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 37. India Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 38. India Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 39. Japan Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 40. Japan Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 41. Japan Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 42. RoAPAC Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 43. RoAPAC Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 44. RoAPAC Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 45. Brazil Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 46. Brazil Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 47. Brazil Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 48. Mexico Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 49. Mexico Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 50. Mexico Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 51. RoLA Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 52. RoLA Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 53. RoLA Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 54. Row Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 55. Row Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 56. Row Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 57. List of secondary sources, used in the study of global Pregabalin Market
  • TABLE 58. List of primary sources, used in the study of global Pregabalin Market
  • TABLE 59. Years considered for the study
  • TABLE 60. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Pregabalin Market, research methodology
  • FIG 2. Global Pregabalin Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Pregabalin Market, key trends 2021
  • FIG 5. Global Pregabalin Market, growth prospects 2022-2028
  • FIG 6. Global Pregabalin Market, porters 5 force model
  • FIG 7. Global Pregabalin Market, pest analysis
  • FIG 8. Global Pregabalin Market, value chain analysis
  • FIG 9. Global Pregabalin Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Pregabalin Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Pregabalin Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Pregabalin Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Pregabalin Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Pregabalin Market, regional snapshot 2018 & 2028
  • FIG 15. North America Pregabalin Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Pregabalin Market 2018 & 2028 (USD Million)
  • FIG 17. Asia pacific Market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Pregabalin Market 2018 & 2028 (USD Million)
  • FIG 19. Global Pregabalin Market, company Market share analysis (2021)
目次

Global Pregabalin Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Pregabalin also called an anticonvulsant is an anti-epileptic medication, used for treatment of neurological conditions such as epilepsy and anxiety. It is also effective in treatment of nerve pain, such as burning, shooting, or stabbing pain. Pregabalin comes in capsules and oral solution. Rising prevalence of epilepsy worldwide and increasing application of Lyrica (Pregabalin) as well as growing healthcare expenditure are driving the growth for Pregabalin Market. For instance, according to World Health Organization (WHO) - as of 2021, around 5 million people are diagnosed with epilepsy every year. This disease is more prevalent in Low- & Middle-income countries. In low-income countries 139 per 100 000 people are affected by epilepsy. Whereas, in high income countries 49 per 100 000 people diagnosed with epilepsy each year . Moreover, in August 20219, The United States Food and Drug Administration granted approvals to nine pharma companies for development of first generic version of Lyrica (pregabalin). These nine companies were Alembic Pharmaceuticals, Alkem Laboratories, Amneal Pharmaceuticals, Dr Reddy's Laboratories, InvaGen Pharmaceuticals, MSN Laboratories, Rising Pharmaceuticals, Sciegen Pharmaceuticals, and Teva Pharmaceuticals. Also, growing number of generic drug manufacturers and rising healthcare sector in emerging markets are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, side effects associated with Pregabalin impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Pregabalin Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to presence of leading market players and favorable government initiatives towards generic drug manufacturing in the region. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as increasing prevalence of neurological disorders and growing healthcare infrastructure in the region, would create lucrative growth prospects for the Pregabalin Market across the Asia Pacific region.

Major market players included in this report are:

Pfizer Inc. (US)

GlaxoSmithKline plc (UK)

Novartis AG (Switzerland)

Mylan N.V. (US)

Teva Pharmaceutical Industries Ltd. (Israel)

Sanofi (France)

F. Hoffmann-La Roche Ltd. (Switzerland)

Aurobindo Pharma (India)

Lupin (India)

Zydus Cadila (India)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Dosage Forms

Oral Capsule

Oral Solution

Oral Tablet

Extended Release

By Application

Epilepsy

Neuropathic Pain

Anxiety Disorder

Others

By Drug Class

Fibromyalgia Agents

Anticonvulsants

Others

By End-Users

Hospitals

Specialty Clinics

Homecare

Others

By Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Pregabalin Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Global Pregabalin Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Global Pregabalin Market, by Application, 2020-2028 (USD Million)
    • 1.2.3. Global Pregabalin Market, by Drug Class, 2020-2028 (USD Million)
    • 1.2.4. Global Pregabalin Market, by Dosage Forms, 2020-2028 (USD Million)
    • 1.2.5. Global Pregabalin Market, by End-Users, 2020-2028 (USD Million)
    • 1.2.6. Global Pregabalin Market, by Distribution Channel, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Pregabalin Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Pregabalin Market Dynamics

  • 3.1. Pregabalin Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising prevalence of epilepsy worldwide.
      • 3.1.1.2. Increasing application of Lyrica (Pregabalin).
      • 3.1.1.3. Growing healthcare expenditure.
    • 3.1.2. Market Challenges
      • 3.1.2.1. Side effects associated with Pregabalin.
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing number of generic drug manufacturers.
      • 3.1.3.2. Rising healthcare sector in emerging Markets.

Chapter 4. Global Pregabalin Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Pregabalin Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Pregabalin Market by Application, Performance - Potential Analysis
  • 6.3. Global Pregabalin Market Estimates & Forecasts by Application 2018-2028 (USD Million)
  • 6.4. Pregabalin Market, Sub Segment Analysis
    • 6.4.1. Epilepsy
    • 6.4.2. Neuropathic Pain
    • 6.4.3. Anxiety Disorder
    • 6.4.4. Others

Chapter 7. Global Pregabalin Market, by Drug Class

  • 7.1. Market Snapshot
  • 7.2. Global Pregabalin Market by Drug Class, Performance - Potential Analysis
  • 7.3. Global Pregabalin Market Estimates & Forecasts by Drug Class 2018-2028 (USD Million)
  • 7.4. Pregabalin Market, Sub Segment Analysis
    • 7.4.1. Fibromyalgia Agents
    • 7.4.2. Anticonvulsants
    • 7.4.3. Others

Chapter 8. Global Pregabalin Market, by Dosage Forms

  • 8.1. Market Snapshot
  • 8.2. Global Pregabalin Market by Dosage Forms, Performance - Potential Analysis
  • 8.3. Global Pregabalin Market Estimates & Forecasts by Dosage Forms 2018-2028 (USD Million)
  • 8.4. Pregabalin Market, Sub Segment Analysis
    • 8.4.1. Oral Capsule
    • 8.4.2. Oral Solution
    • 8.4.3. Oral Tablet
    • 8.4.4. Extended Release

Chapter 9. Global Pregabalin Market, by End-Users

  • 9.1. Market Snapshot
  • 9.2. Global Pregabalin Market by End-Users, Performance - Potential Analysis
  • 9.3. Global Pregabalin Market Estimates & Forecasts by End-Users 2018-2028 (USD Million)
  • 9.4. Pregabalin Market, Sub Segment Analysis
    • 9.4.1. Hospitals
    • 9.4.2. Specialty Clinics
    • 9.4.3. Homecare
    • 9.4.4. Others

Chapter 10. Global Pregabalin Market, by Distribution Channel

  • 10.1. Market Snapshot
  • 10.2. Global Pregabalin Market by Distribution Channel, Performance - Potential Analysis
  • 10.3. Global Pregabalin Market Estimates & Forecasts by Distribution Channel 2018-2028 (USD Million)
  • 10.4. Pregabalin Market, Sub Segment Analysis
    • 10.4.1. Hospital Pharmacy
    • 10.4.2. Retail Pharmacy
    • 10.4.3. Online Pharmacy
    • 10.4.4. Others

Chapter 11. Global Pregabalin Market, Regional Analysis

  • 11.1. Pregabalin Market, Regional Market Snapshot
  • 11.2. North America Pregabalin Market
    • 11.2.1. U.S. Pregabalin Market
      • 11.2.1.1. Application estimates & forecasts, 2018-2028
      • 11.2.1.2. Drug Class estimates & forecasts, 2018-2028
      • 11.2.1.3. Dosage Forms estimates & forecasts, 2018-2028
      • 11.2.1.4. End-Users estimates & forecasts, 2018-2028
      • 11.2.1.5. Distribution Channel estimates & forecasts, 2018-2028
    • 11.2.2. Canada Pregabalin Market
  • 11.3. Europe Pregabalin Market Snapshot
    • 11.3.1. U.K. Pregabalin Market
    • 11.3.2. Germany Pregabalin Market
    • 11.3.3. France Pregabalin Market
    • 11.3.4. Spain Pregabalin Market
    • 11.3.5. Italy Pregabalin Market
    • 11.3.6. Rest of Europe Pregabalin Market
  • 11.4. Asia-Pacific Pregabalin Market Snapshot
    • 11.4.1. China Pregabalin Market
    • 11.4.2. India Pregabalin Market
    • 11.4.3. Japan Pregabalin Market
    • 11.4.4. Australia Pregabalin Market
    • 11.4.5. South Korea Pregabalin Market
    • 11.4.6. Rest of Asia Pacific Pregabalin Market
  • 11.5. Latin America Pregabalin Market Snapshot
    • 11.5.1. Brazil Pregabalin Market
    • 11.5.2. Mexico Pregabalin Market
  • 11.6. Rest of The World Pregabalin Market

Chapter 12. Competitive Intelligence

  • 12.1. Top Market Strategies
  • 12.2. Company Profiles
    • 12.2.1. Pfizer Inc. (US)
      • 12.2.1.1. Key Information
      • 12.2.1.2. Overview
      • 12.2.1.3. Financial (Subject to Data Availability)
      • 12.2.1.4. Product Summary
      • 12.2.1.5. Recent Developments
    • 12.2.2. GlaxoSmithKline plc (UK)
    • 12.2.3. Novartis AG (Switzerland)
    • 12.2.4. Mylan N.V. (US)
    • 12.2.5. Teva Pharmaceutical Industries Ltd. (Israel)
    • 12.2.6. Sanofi (France)
    • 12.2.7. F. Hoffmann-La Roche Ltd. (Switzerland)
    • 12.2.8. Aurobindo Pharma (India)
    • 12.2.9. Lupin (India)
    • 12.2.10. Zydus Cadila (India)

Chapter 13. Research Process

  • 13.1. Research Process
    • 13.1.1. Data Mining
    • 13.1.2. Analysis
    • 13.1.3. Market Estimation
    • 13.1.4. Validation
    • 13.1.5. Publishing
  • 13.2. Research Attributes
  • 13.3. Research Assumption